| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S003118201900009X |
| P698 | PubMed publication ID | 30782223 |
| P50 | author | Reggiani Vilela Gonçalves | Q56779174 |
| Rômulo Dias Novaes | Q59689997 | ||
| P2093 | author name string | Ana Lia Mazzeti | |
| Lívia F Diniz | |||
| Thaiany G Souza-Silva | |||
| Andrea A S Mendonça | |||
| P2860 | cites work | The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions | Q27860564 |
| The Epidemiology, Clinical Manifestations, and Management of Chagas Heart Disease | Q28084634 | ||
| Pathogenesis of chagas' disease: parasite persistence and autoimmunity | Q28742827 | ||
| Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer. | Q30725083 | ||
| Evaluation of methodological search filters--a review | Q31106897 | ||
| Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hemopoiesis and intracellular control of parasite growth | Q33369511 | ||
| Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium | Q33399862 | ||
| Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage | Q33705192 | ||
| Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway | Q33903180 | ||
| Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi. | Q43467779 | ||
| Changes in cellular contractility and cytokines profile during Trypanosoma cruzi infection in mice | Q43935085 | ||
| Biological aspects of the Dm 28c clone of Trypanosoma cruzi after metacyclogenesis in chemically defined media | Q44071500 | ||
| Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats | Q44279656 | ||
| Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse | Q44290472 | ||
| Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. | Q44296798 | ||
| Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice | Q46902687 | ||
| Ex vivo T-lymphocyte chemokine receptor phenotypes in patients with chronic Chagas disease | Q47379412 | ||
| Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. | Q47912416 | ||
| Could age and aging change the host response to systemic parasitic infections? A systematic review of preclinical evidence | Q48023168 | ||
| Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major | Q49219150 | ||
| Genetic Analysis of Human Norovirus Strains in Japan in 2016-2017. | Q49702596 | ||
| Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection | Q49969266 | ||
| Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. | Q51791414 | ||
| Challenges of immunosuppressive and antitrypanosomal drug therapy after heart transplantation in patients with chronic Chagas disease: A systematic review of clinical recommendations. | Q53283901 | ||
| Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. | Q53568433 | ||
| Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages. | Q54573248 | ||
| Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells | Q57275755 | ||
| The binding of CCL2 to the surface of Trypanosoma cruzi induces chemo-attraction and morphogenesis | Q58439075 | ||
| Functional capacity in Chagas disease | Q58842260 | ||
| Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage | Q58844486 | ||
| Chagas cardiomyopathy and captopril | Q58844554 | ||
| Captopril Ameliorates Myocarditis in Acute Experimental Chagas Disease | Q58845984 | ||
| Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy | Q69733282 | ||
| On the tissular parasitism of Trypanosoma cruzi Y strain in Swiss mice | Q70419761 | ||
| Angiotensin-converting-enzyme inhibitors suppress synthesis of tumour necrosis factor and interleukin 1 by human peripheral blood mononuclear cells | Q70948219 | ||
| Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension | Q73263072 | ||
| The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production | Q77394085 | ||
| Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension | Q34118875 | ||
| American trypanosomiasis (Chagas disease). | Q34277333 | ||
| Sm16, a major component of Schistosoma mansoni cercarial excretory/secretory products, prevents macrophage classical activation and delays antigen processing. | Q34979258 | ||
| Factors related to first dose hypotensive effect of captopril: prediction and treatment. | Q34991422 | ||
| ECG Detection of Murine Chagasic Cardiomyopathy | Q35148047 | ||
| The carboxypeptidase ACE shapes the MHC class I peptide repertoire | Q35402189 | ||
| IL-10 limits parasite burden and protects against fatal myocarditis in a mouse model of Trypanosoma cruzi infection | Q35659197 | ||
| Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism | Q35746981 | ||
| Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection | Q35884259 | ||
| Enalapril in Combination with Benznidazole Reduces Cardiac Inflammation and Creatine Kinases in Mice Chronically Infected with Trypanosoma cruzi | Q36436221 | ||
| Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease | Q36668496 | ||
| Molecular and cellular mechanisms involved in the Trypanosoma cruzi/host cell interplay | Q37007967 | ||
| Apoptotic CD8 T-lymphocytes disable macrophage-mediated immunity to Trypanosoma cruzi infection. | Q37030324 | ||
| Regulation of T-cell function by endogenously produced angiotensin II. | Q37100479 | ||
| Trypanosoma cruzi: adaptation to its vectors and its hosts | Q37224052 | ||
| Chagas cardiomyopathy--where do we stand after a hundred years? | Q37683028 | ||
| Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps. | Q37717875 | ||
| Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence | Q37984645 | ||
| Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases | Q38161684 | ||
| Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes | Q38325800 | ||
| The immunomodulatory effects of the Enalapril in combination with Benznidazole during acute and chronic phases of the experimental infection with Trypanosoma cruzi | Q38673340 | ||
| Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert | Q38788237 | ||
| Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial | Q39146653 | ||
| Applicability of plant-based products in the treatment of Trypanosoma cruzi and Trypanosoma brucei infections: a systematic review of preclinical in vivo evidence. | Q39348896 | ||
| Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment | Q39372743 | ||
| Molecular characterization of lipoamide dehydrogenase gene in Trypanosoma cruzi populations susceptible and resistant to benznidazole | Q39446821 | ||
| Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. | Q39673704 | ||
| Biology of Trypanosoma cruzi | Q39879813 | ||
| ACE2 overexpression inhibits angiotensin II-induced monocyte chemoattractant protein-1 expression in macrophages | Q40029396 | ||
| Trypanosoma cruzi: Role of the immune response in the natural resistance of inbred strains of mice | Q40165442 | ||
| Acute phase of Chagas disease in the Brazilian Amazon region: study of 233 cases from Pará, Amapá and Maranhão observed between 1988 and 2005 | Q40399672 | ||
| Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages | Q40942142 | ||
| Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes | Q41573426 | ||
| Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. | Q42332476 | ||
| Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors | Q42944340 | ||
| Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease | Q43096490 | ||
| Absence of CD4+ T lymphocytes, CD8+ T lymphocytes, or B lymphocytes has different effects on the efficacy of posaconazole and benznidazole in treatment of experimental acute Trypanosoma cruzi infection | Q43215508 | ||
| Chagas disease in Australia and New Zealand: risks and needs for public health interventions | Q43412051 | ||
| P433 | issue | 7 | |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | 914-927 | |
| P577 | publication date | 2019-02-20 | |
| P1433 | published in | Parasitology | Q15753259 |
| P1476 | title | Could angiotensin-modulating drugs be relevant for the treatment of Trypanosoma cruzi infection? A systematic review of preclinical and clinical evidence | |
| P478 | volume | 146 |
Search more.